13F filer · CIK 2011385
Catalys Pacific, LLC
Tokyo, M0 · filing since Q4 2023 · last filing Oct 30, 2026
Reported value
$209.7M
$-19.7M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
1 / 1
Turnover
1.2%
buys $2.8M · sells $2.6M
Top-10 weight
100.0%
Biggest buys vs Q2 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | Phathom Pharmaceuticals, Inc. | +388,185 | +26.0% | +$2.8M |
Biggest sells vs Q2 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | Mineralys Therapeutics, Inc. | -104,320 | -1.3% | $-2.6M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Mineralys Therapeutics, Inc.COM | 7,799,518 | $196.0M | 93.45% |
| 2 | Phathom Pharmaceuticals, Inc.COM | 1,882,039 | $13.7M | 6.55% |